Today: 17 May 2026
Browse Category

NASDAQ:EVC 7 May 2026

Entravision Communications (EVC) Stock Nearly Doubles as AI Ad-Tech Revenue Surges

Entravision Communications (EVC) Stock Nearly Doubles as AI Ad-Tech Revenue Surges

Entravision shares surged 94% to $7.69 after first-quarter revenue more than doubled to $196.97 million and net income reached $12.36 million, reversing a year-ago loss. The Advertising Technology & Services unit drove a 204% revenue jump to $154.55 million. Broadcast revenue rose 4% but posted a wider operating loss. Cash flow turned positive, with $21.8 million generated in the quarter.
7 May 2026
··

Stock Market Today

  • Siemens Healthineers Valuation Review After Share Price Dip
    May 16, 2026, 8:04 PM EDT. Siemens Healthineers (XTRA:SHL) shares fell 2.1% in one day and 12.9% over the past month to €33.4, amid fading momentum and cooled investor sentiment. Despite the pullback, the stock trades at a roughly 38-58% discount to intrinsic value and analyst targets averaging €49.58-€53.47, suggesting potential undervaluation. Growth prospects are supported by rising demand for precision diagnostics amid aging populations and chronic disease trends. However, risks include tariff challenges and China's market weakness, which may pressure margins. Investors are advised to weigh key growth drivers against these risks when considering Siemens Healthineers for healthcare technology exposure.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop